Immunocore Holdings plc
IMCR
$30.34
-$0.39-1.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.51M | -29.23M | -20.31M | -21.63M | -51.09M |
| Total Depreciation and Amortization | 3.27M | 3.60M | 3.84M | 4.05M | 4.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.84M | 20.24M | 17.34M | 15.46M | 23.99M |
| Change in Net Operating Assets | -9.30M | 13.38M | 32.71M | 33.20M | 48.95M |
| Cash from Operations | -10.71M | 7.99M | 33.58M | 31.08M | 26.06M |
| Capital Expenditure | -4.34M | -5.04M | -5.12M | -5.04M | -5.17M |
| Sale of Property, Plant, and Equipment | -- | 44.00K | 44.00K | 44.00K | 44.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.00M | -14.00M | -20.00M | -340.00M | -350.00M |
| Cash from Investing | -16.34M | -19.00M | -25.08M | -345.00M | -355.13M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 402.50M |
| Total Debt Repaid | -- | -52.06M | -52.06M | -52.06M | -52.06M |
| Issuance of Common Stock | 12.37M | 8.64M | 6.97M | 3.60M | 6.80M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -1.12M | -13.36M |
| Cash from Financing | 12.37M | -43.42M | -45.09M | -49.58M | 343.88M |
| Foreign Exchange rate Adjustments | 26.66M | 15.08M | 19.55M | 7.52M | -1.71M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.98M | -39.35M | -17.05M | -355.98M | 13.11M |